Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer
Abstract Limited understanding of ovarian cancer (OC) genome portrait has hindered the therapeutic advances. The serial monitoring of tumor genotypes is becoming increasingly attainable with circulating cell-free DNA (cf-DNA) and circulating tumor cells (CTCs) emerging as "liquid biopsies"...
Saved in:
Main Authors: | Xianliang Cheng (Author), Lei Zhang (Author), Yajuan Chen (Author), Chen Qing (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer
by: Hei-Jen Jou, et al.
Published: (2022) -
Circulating cell-free DNA biomarkers
by: Jose Rafael Villarreal Escorcia
Published: (2021) -
Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer
by: Yu Ran Park, et al.
Published: (2018) -
Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
by: Hyun-Ji Lee, et al.
Published: (2018) -
Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma
by: Dóra Mihály, et al.
Published: (2018)